1995 Bachelor of Science, Biomedical Engineering, Northwestern University, Evanston, IL
1999 Medical Degree, Northwestern University Medical School, Chicago, IL
2002 Internal Medicine, University Hospitals of Cleveland/Case Western University, Cleveland, OH
2005 Allergy/Immunology Fellowship, Massachusetts General Hospital, Boston, MA
Clinical trials from two international research teams have shown that icatibant, a new drug that blocks the action of an inflammatory protein known as bradykinin, is safe and effective in treating acute attacks of hereditary angioedema, a potentially life-threatening condition.